Mpn1, mutated in poikiloderma with neutropenia protein 1, is a conserved 3'-to-5' RNA exonuclease processing U6 small...

Area of Science:

• Molecular Biology
• Genetics
• RNA Metabolism

Background:

• Clericuzio-type poikiloderma with neutropenia (PN) is a rare genodermatosis linked to C16orf57 gene mutations.
• The C16orf57 gene encodes the uncharacterized protein hMpn1, whose function is unknown.

Purpose of the Study:

• To elucidate the function of the Mpn1 protein.
• To investigate the role of Mpn1 in RNA processing and its connection to PN pathogenesis.

Main Methods:

• Investigated Mpn1 function in fission yeast (mpn1Δ) and human cell lines.
• Analyzed U6 small nuclear RNA (snRNA) processing and stability.
• Performed in vitro assays with recombinant hMpn1 protein.
• Assessed precursor messenger RNA splicing and U4/U6 di-small nuclear RNA protein complex levels.

Main Results:

• Mpn1 functions as a 3'-to-5' RNA exonuclease, processing the 3' end of U6 snRNA.
• Mpn1 deficiency leads to elongated U6 3' polyuridine tails and loss of the 2',3' cyclic phosphate group.
• Absence of Mpn1 causes diminished U6 snRNA and U4/U6 complex levels, resulting in splicing defects.
• U6 snRNA degradation rates increase in Mpn1-deficient cells.

Conclusions:

• Mpn1 is essential for the posttranscriptional processing and stability of U6 snRNA.
• Altered U6 snRNA metabolism due to Mpn1 deficiency is implicated in the pathogenesis of PN.
• Restoring Mpn1 function or U6 levels can revert splicing defects.